Robert O’Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA
An Update on Statistical Issues Associated with the International Harmonization of Technical Standards for Clinical Trials (ICH). Robert O’Neill , Ph.D. Director, Office of Biostatistics, CDER, FDA. 22nd Spring Symposium, New Jersey Chapter of ASA, Wed. June 6,2001. Outline of talk.
909 views • 68 slides